CLINICAL_TRIALS
withdrawal
· 2021-01-08
Clinical Trial Update: Letrozole for Frozen Embryo Transfer (FET) in Patients With Polycystic Ovary Syndrome (PCOS) [Phase 4]
Summary
Phase 4 trial of letrozole for frozen embryo transfer in PCOS patients has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: CRG UZ Brussel | Conditions: Infertility, Female, Polycystic Ovary Syndrome | Phase 4 | Status: WITHDRAWN